XML 17 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Cash flows from operating activities:    
Net loss $ (8,068) $ (13,593)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 975 1,052
Amortization of deferred financing costs and debt discount 212 418
Provision for excess inventory 398 340
Share-based compensation expense 239 410
Loss on asset disposal 20 19
Increases (decreases) in cash caused by changes in operating assets and liabilities:    
Accounts receivable (274) 409
Inventories 371 159
Other current assets 344 (736)
Other assets (1) 43
Accounts payable and accrued expenses (1,165) (194)
Deferred revenues 123 13
Long-term deferred rent (14) 119
Net cash used in operating activities (6,840) (9,855)
Cash flows from investing activities:    
Purchases of property and equipment /long-lived assets (78) (95)
Net cash used in investing activities (78) (1,296)
Cash flows from financing activities:    
Principal payments on long-term obligations 0 (3,540)
Proceeds from sale of common stock, net (200) 11,225
Net cash (used in) provided by financing activities (200) 7,685
Effect of exchange rate changes on cash and cash equivalents 12 13
Net decrease in cash and cash equivalents (7,106) (3,453)
Cash, cash equivalents, and restricted cash at beginning of period 10,225 12,910
Cash, cash equivalents, and restricted cash at end of period 3,119 9,457
Cash paid during period for:    
Interest 649 740
Supplemental schedule of non-cash investing and financing activities:    
Conversion of preferred stock into common stock 4 0
Azaya Therapeutics, Inc. [Member]    
Adjustments to reconcile net loss to net cash used in operating activities:    
In process research and development acquired from Azaya Therapeutics 0 1,686
Cash flows from investing activities:    
Purchases of property and equipment /long-lived assets 0 (1,201)
Supplemental schedule of non-cash investing and financing activities:    
Common stock issued in payment for the assets acquired $ 0 $ 2,311